Cholesterol emboli syndrome historical perspective: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Cholesterol emboli syndrome}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Reference...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cholesterol emboli syndrome}}
{{Cholesterol emboli syndrome}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
{{CMG}}
==Overview==
==Historical Perspective==
The phenomenon of embolisation of cholesterol was first recognized by the Danish [[physiology|physiologist]] Dr [[Peter Ludvig Panum]].<ref>{{cite journal | author=Panum PL | title=Experimentelle Beitrage zur Lehre von der Embolie | language=German | journal=Virchows Arch Pathol Anat Physiol | year=1862 | volume=25 | pages=308–310 | doi=10.1007/BF01879803}}</ref> Further pathological evidence that eroded atheroma was the source of emboli came from American [[pathology|pathologist]] Dr Curtis M. Flory, who reported the phenomenon in 3.4% of a large series of patients with severe atherosclerosis of the [[aorta]].<ref>{{cite journal | author=Flory CM | title=Arterial occlusions produced by emboli from eroded aortic atheromatous plaques | journal=Am J Pathol | year= 1945 | volume=21 | pages=549–565}} {{PMC|1934118}}</ref><ref name=Modi/>
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 14:08, 27 September 2012

Cholesterol emboli syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Cholesterol emboli syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholesterol emboli syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholesterol emboli syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholesterol emboli syndrome historical perspective

CDC on Cholesterol emboli syndrome historical perspective

Cholesterol emboli syndrome historical perspective in the news

Blogs on Cholesterol emboli syndrome historical perspective

Directions to Hospitals Treating Cholesterol emboli syndrome

Risk calculators and risk factors for Cholesterol emboli syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

The phenomenon of embolisation of cholesterol was first recognized by the Danish physiologist Dr Peter Ludvig Panum.[1] Further pathological evidence that eroded atheroma was the source of emboli came from American pathologist Dr Curtis M. Flory, who reported the phenomenon in 3.4% of a large series of patients with severe atherosclerosis of the aorta.[2][3]

References

  1. Panum PL (1862). "Experimentelle Beitrage zur Lehre von der Embolie". Virchows Arch Pathol Anat Physiol (in German). 25: 308–310. doi:10.1007/BF01879803.
  2. Flory CM (1945). "Arterial occlusions produced by emboli from eroded aortic atheromatous plaques". Am J Pathol. 21: 549–565. PMC 1934118


Template:WikiDoc Sources